LIN9 Antikörper (AA 5-103) (HRP)
Kurzübersicht für LIN9 Antikörper (AA 5-103) (HRP) (ABIN7165765)
Target
Alle LIN9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 5-103
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Protein lin-9 homolog protein (5-103AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- LIN9 (Lin-9 Homolog (LIN9))
-
Andere Bezeichnung
- LIN9
-
Hintergrund
-
Background: Acts as a tumor suppressor. Inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. Plays a role in the expression of genes required for the G1/S transition.
Aliases: BARA antibody, Beta subunit-associated regulator of apoptosis antibody, Beta-subunit associated regulator of apoptosis antibody, hLin-9 antibody, huLin-9 antibody, lin-9 antibody, lin9 antibody, LIN9_HUMAN antibody, pRB-associated protein antibody, Protein lin-9 homolog antibody, TGS antibody, TUDOR gene similar protein antibody, Type I interferon receptor beta chain-associated protein antibody
-
UniProt
- Q5TKA1
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-